Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRH in depressive illness.

J C Pecknold, T A Ban

    International Pharmacopsychiatry
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Thyrotropin-releasing hormone (TRH) acts centrally, showing psychostimulant effects and transiently improving unipolar depression in women. TRH response may predict effectiveness of norepinephrine uptake inhibitors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chronic schizophrenia-a psychopharmacological aproach.

    Indian journal of psychiatry·2011
    Same author

    Adynamic ileus during psychoactive medication.

    Canadian Medical Association journal·2010
    Same author

    Dose equivalent for haloperidol and phenothiazines.

    Canadian Medical Association journal·2010
    Same author

    Non-equivalence of anti-psychotic drugs.

    Canadian Medical Association journal·2010
    Same author

    Pharmacotherapy of depression: a historical analysis.

    Journal of neural transmission (Vienna, Austria : 1996)·2001
    Same author

    Pharmacotherapy of mental illness--a historical analysis.

    Progress in neuro-psychopharmacology & biological psychiatry·2001
    Same journal

    A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.

    International pharmacopsychiatry·1982
    Same journal

    Zopiclone: sleep and performance studies in healthy man.

    International pharmacopsychiatry·1982
    Same journal

    Pharmacokinetics and metabolism of zopiclone.

    International pharmacopsychiatry·1982
    Same journal

    Evaluation of zopiclone physical dependence liability in normal volunteers.

    International pharmacopsychiatry·1982
    Same journal

    Dose-finding and premedication studies with zopiclone.

    International pharmacopsychiatry·1982
    Same journal

    Efficacy and tolerance of zopiclone in insomniac geriatric patients.

    International pharmacopsychiatry·1982
    See all related articles

    Area of Science:

    • Neuroendocrinology
    • Psychopharmacology

    Background:

    • Four hypothalamic-releasing hormones (TRH, SRIF, LHRH, MIF) possess CNS actions and potential psychotropic properties.
    • Thyrotropin-releasing hormone (TRH) is the most extensively researched among these.
    • TRH exhibits a central neurophysiological role independent of the pituitary-thyroid axis.

    Purpose of the Study:

    • To explore the psychotropic properties and clinical effects of Thyrotropin-releasing hormone (TRH).
    • To investigate the potential of TRH response as a predictor for specific antidepressant therapies.

    Main Methods:

    • Review of animal pharmacological data on TRH's central nervous system activity.
    • Analysis of human pharmacological studies, including computer EEG profiles.
    • Evaluation of clinical findings regarding TRH's effects on unipolar depression and related symptoms.

    Related Experiment Videos

    Main Results:

    • Animal studies confirm TRH's central action and neurophysiological role.
    • Human EEG studies show TRH's profile resembles psychostimulants and secondary amine tricyclic antidepressants.
    • TRH administration resulted in rapid, transient improvements in unipolar depression, energy, well-being, and libido in women.

    Conclusions:

    • TRH demonstrates significant psychotropic effects and clinical utility in specific patient populations.
    • A transient positive response to TRH may identify patients who will benefit from maprotiline or other norepinephrine uptake inhibitors.